Search results for "PRODUCT"

showing 10 items of 13045 documents

Food consumption and nutrient intakes with a special focus on milk product consumption in early pubertal girls in Central Finland

2005

AbstractObjectiveTo evaluate the current status of dietary intakes in early pubertal girls with a special focus on milk products.DesignCross-sectional data using 3-day food records.SubjectsEight hundred and sixty girls, aged 10–12 years, at Tanner maturation stage I-III.ResultsThe mean consumption of milk products (620 g day−1) was similar to that of a Finnish study in the 1980s, while the consumption of non-milk drinks (403 gday−1) had increased. Twelve per cent of the girls had a dairy-restricted diet and consumed significantly less milk products than girls with a non-restricted diet (465 vs. 644 g day−1, P<0.001). Girls with low milk product consumption had the highest non-milk drinks…

medicine.medical_specialty030309 nutrition & dieteticsNutrition EducationSaturated fatFood consumptionNutritional StatusMedicine (miscellaneous)030209 endocrinology & metabolismDiet SurveysStatistics Nonparametric03 medical and health sciences0302 clinical medicineAnimal scienceNutrientMilk productsInternal medicinemedicineAnimalsHumansVitamin DChildFinland2. Zero hungerConsumption (economics)Analysis of Variance0303 health sciencesNutrition and Dieteticsbusiness.industryPubertyPublic Health Environmental and Occupational HealthVitamin D intakeFeeding BehaviorDietary FatsCalcium DietaryCross-Sectional StudiesMilkEndocrinologyDiet qualityFemaleEnergy IntakebusinessPublic Health Nutrition
researchProduct

P–298 High prevalence of depression and anxiety in patients with endometriosis during the SARS-CoV–2 pandemic in Germany

2021

Abstract Study question The aim was to assess the prevalence of self-reported symptoms of depression and anxiety and the moderating factors influencing mental symptoms during the COVID–19 pandemic. Summary answer Endometriosis patients were at risk of developing mental disorders during the pandemic. Associated risk factors were: reduction of the social network and the employment status. What is known already Endometriosis is a disease affecting up to 10% of women of fertile age. The leading symptoms are sub- or infertility and chronic pain. Additionally, the psychological impact on womeńs life is enormous. Women with endometriosis show higher rates of depression, anxiety and emotional distr…

medicine.medical_specialty2019-20 coronavirus outbreakHigh prevalencebusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)RehabilitationEndometriosisObstetrics and Gynecologymedicine.diseaseAcademicSubjects/MED00905Endometriosis Endometrium and Fallopian Tube and Benign Disorders of the Endometrium and Fallopian TubePoster ViewingReproductive MedicineInternal medicinePandemicMedicineAnxietyIn patientmedicine.symptombusinessDepression (differential diagnoses)Human Reproduction (Oxford, England)
researchProduct

Self-reported symptoms in women with diastasis rectus abdominis: A systematic review

2021

Abstract Introduction Diastasis rectus abdominis (DRA) diagnosis via clinical examination is well defined, however, the assessment of symptoms has been less investigated. Currently, there is also scant knowledge on the consequences of DRA. The aim of this review is to identify the relevant self-reported variables in the study of DRA in women. Methods We performed a systematic review of observational studies through Medline, Embase, and Cochrane Library databases. Studies evaluating the link between DRA and self-reported symptoms were searched using the following terms: "Diastasis rectus abdominis", "Diastasis recti", "Abdominis Rectus Muscle Diastasis", "Questionnaire", "Scale", "Survey", "…

medicine.medical_specialtyAbdominal painDiastasis MuscleRectus AbdominisUrinary incontinencePhysical examinationPelvic Floor DisordersDiagnostic Self Evaluation03 medical and health sciences0302 clinical medicinePelvic floor dysfunctionQuality of lifeBody ImagemedicineHumansDiastasis rectiMuscle Weakness030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryObstetrics and Gynecologymedicine.diseaseLow back painAbdominal PainReproductive Medicine030220 oncology & carcinogenesisQuality of LifeDiastasisPhysical therapyFemaleSelf ReportSymptom Assessmentmedicine.symptombusinessLow Back PainJournal of Gynecology Obstetrics and Human Reproduction
researchProduct

Medical abortion: Teratogenic effects of misoprostol.

2015

Some 40 million abortions are performed around the world every year. In Spain, this figure reached 112,390 in 2011. Of these, approximately 5% were medical abortions. This percentage varies widely ...

medicine.medical_specialtyAbortifacient AgentsObstetricsbusiness.industrymedicine.medical_treatmentMEDLINEObstetrics and GynecologyAbnormalities Drug-InducedAbortionMedical abortionembryonic structuresmedicineHumansFemalebusinessAbortion TherapeuticMisoprostolreproductive and urinary physiologyMisoprostolmedicine.drugJournal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
researchProduct

Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors

2002

In order to evaluate the prevalence, risk factors, and clinical consequences of hypovitaminosis D in elderly Italian women a multicenter study of 43 osteoporosis centers from all regions of Italy was carried out. Study population included 700 women aged 60-80 years in whom blood was taken for 25-hydroxyvitamin D (25OHD) and parathyroid hormone (PTH) measurements. All subjects were also questioned to assess the prevalence of several risk factors for hypovitaminosis D, osteoporotic fractures and activities of daily living (ADL). Values of 25OHD lower than 5 ng/ml were found in 27% of the women and lower than 12 ng/ml in 76%. 25OHD and PTH levels were negatively correlated ( r=-0.38, after log…

medicine.medical_specialtyActivities of daily livingEndocrinology Diabetes and MetabolismOsteoporosisPopulationvitamin D deficiencyRisk FactorsPrevalencemedicineVitamin D and neurologyHumansRisk factoreducationAged25-Hydroxyvitamin D 2Aged 80 and overHip fractureeducation.field_of_studybusiness.industrySmokingMiddle AgedVitamin D Deficiencymedicine.diseaseDietItalyParathyroid HormonePhysical therapyEducational StatusPopulation studyFemaleDairy ProductsbusinessDemographyOsteoporosis International
researchProduct

Endoscopic management of a case of 'complete septate uterus with unilateral haematometra'

1995

Endoscopy and ultrasound was used to diagnose a 13 year old virgin girl who presented with dysmenorrhoea and suspected right side adnexal tumescence. The girl was found to have a complete septate uterus with non-communicating right hemicavity and haematometra, an exceptional type of Mullerian anomaly. After pretreatment with buserelin, hysteroscopic metroplasty was successfully performed.

medicine.medical_specialtyAdolescentUterusHysteroscopyBuserelinDysmenorrheaHematometraMedicineHumansUltrasonographyHematometraTumescencemedicine.diagnostic_testbusiness.industryRehabilitationUterusObstetrics and Gynecologymedicine.diseaseCombined Modality TherapyBuserelinEndoscopySurgerymedicine.anatomical_structureTreatment OutcomeReproductive MedicineHysteroscopyFemalebusinessHaematometraSeptate uterusmedicine.drug
researchProduct

Ovarian volume in normal and hyperandrogenic adolescent women

2015

Objective To study the threshold for increased ovarian size during different periods of adolescence. Design Cross sectional study with retrospective analysis. Setting University center. Patient(s) A total of 146 hyperandrogenic adolescent women and 72 healthy adolescent controls. Intervention(s) Intravaginal or transabdominal ovarian sonography. Main Outcome Measure(s) Determination of normal ovarian size during the different phases of adolescence calculated using the ellipsoid formula; calculation of threshold for increased ovarian size during different adolescent gynecologic ages and prevalence of increased ovarian size for hyperandrogenic girls at different gynecologic ages. Result(s) In…

medicine.medical_specialtyAdolescentendocrine system diseasesCross-sectional studyRetrospective analysisHumansMedicineChildRetrospective StudiesUltrasonographyGynecologybusiness.industryOvaryHyperandrogenismAge FactorsOutcome measuresObstetrics and GynecologyOrgan Sizemedicine.diseasePolycystic ovaryCross-Sectional StudiesReproductive MedicineMenarcheFemaleHyperandrogenismbusinessFertility and Sterility
researchProduct

Physical activity and healthy aging.

2016

medicine.medical_specialtyAging030219 obstetrics & reproductive medicinebusiness.industryPhysical activityMEDLINEObstetrics and GynecologyMotor ActivityHealthy Aging03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationMedicineHumans030212 general & internal medicineMotor activityHealthy agingbusinessExerciseMenopause (New York, N.Y.)
researchProduct

The metabolism and availability of essential fatty acids in animal and human tissues.

1994

Essential fatty acids (EFA), which are not synthesized in animal and human tissues, belong to the n-6 and n-3 families of polyunsaturated fatty acids (PUFA), derived from linoleic acid (LA, 18:2n-6) and alpha-linolenic acid (LNA, 18:3n-3). Optimal requirements are 3-6% of ingested energy for LA and 0.5-1% for LNA in adults. Requirements in LNA are higher in development. Dietary sources of LA and LNA are principally plants, while arachidonic acid (AA, 20:4n-6) is found in products from terrestrian animals, and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are found in products from marine animals. EFA are principally present in dietary triacylglycerols, which should be hydrolyze…

medicine.medical_specialtyAgingLinolenic acidLinoleic acidBiological AvailabilityBiologyIntestinal absorptionchemistry.chemical_compoundInternal medicine[SDV.BDD] Life Sciences [q-bio]/Development BiologymedicineAnimalsHumansNutritional Physiological Phenomena[SDV.BDLR] Life Sciences [q-bio]/Reproductive Biologychemistry.chemical_classificationFatty Acids EssentialNutritional Requirementsfood and beveragesMetabolismEicosapentaenoic acidDietary FatsHormones[SDV.AEN] Life Sciences [q-bio]/Food and NutritionEndocrinologyBiochemistrychemistryIntestinal AbsorptionDocosahexaenoic acidOrgan Specificitylipids (amino acids peptides and proteins)Arachidonic acidDigestionPolyunsaturated fatty acidReproduction, nutrition, development
researchProduct

Current management of pelvic organ prolapse in aging women : EMAS clinical guide

2018

Management of pelvic organ prolapse (POP) is a common and challenging task. Nowadays older women are more active than they were in the past, and the development of POP disrupts quality of life and impairs social and personal activities. The menopausal transition is a time of vulnerability, during which many women start experiencing symptoms and signs of POP. The role of hormonal changes or of hormonal therapies in influencing the development or progression of POP has been explored extensively. The management of POP requires considerable clinical skills. Correct diagnosis and characterization of the prolapse and an identification of the individual woman's most bothersome symptoms are the hal…

medicine.medical_specialtyAginggenetic structuresFLOOR DISORDERSUrinary incontinenceUrinary incontinencebehavioral disciplines and activitiesGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialMultidisciplinary approachlawQUALITY-OF-LIFE3123 Gynaecology and paediatricsmedicineHumans030212 general & internal medicineIntensive care medicineGENITOURINARY SYNDROMECompetence (human resources)AgedICS JOINT REPORTPelvic organ030219 obstetrics & reproductive medicineVULVO-VAGINAL ATROPHYbusiness.industryObstetrics and GynecologyLAPAROSCOPIC LATERAL SUSPENSIONERYAG LASER TREATMENTmedicine.diseaseSTRESS URINARY-INCONTINENCEOptimal management3. Good healthPelvic organ prolapseManagementMenopauseAging; Management; Pelvic organ prolapse; Urinary incontinenceCurrent managementPOSTMENOPAUSAL WOMEN3121 General medicine internal medicine and other clinical medicineRANDOMIZED-CONTROLLED-TRIALFemaleMenopausemedicine.symptombusiness
researchProduct